VEGFA and fibrosis: No significant differences were found between the fibrosis and non-fibrosis groups in terms of gender (p = 0.148), age (p = 0.345), smoking history (p = 1.000), number of injections in 1 year (p = 0.407), type of anti-VEGF drugs used (p = 0.655), or other factors.